{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:52:28Z","timestamp":1792021948364,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Natural Science Foundation","doi-asserted-by":"crossref","award":["LQ21H030003"],"award-info":[{"award-number":["LQ21H030003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovative Research Groups of National Natural Science Foundation of China","award":["81721091"],"award-info":[{"award-number":["81721091"]}]},{"name":"Research Unit Project of Chinese Academy of Medical Sciences","award":["2019-I2M-5-030"],"award-info":[{"award-number":["2019-I2M-5-030"]}]},{"name":"Ministry of Science and Technology of the People\u2019s Republic of China, 13th Five-Year National Science and Technology Major Project","award":["2018ZX10715-013-003"],"award-info":[{"award-number":["2018ZX10715-013-003"]}]},{"name":"Ministry of Science and Technology of the People\u2019s Republic of China, 13th Five-Year National Key Research and Development Program of China","award":["2019YFC0840600"],"award-info":[{"award-number":["2019YFC0840600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14268-9","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:33:26Z","timestamp":1747157606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preoperative plasma cell-free DNA chromosomal instability predicts microvascular invasion in hepatocellular carcinoma: a prospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Zheyue","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"1","key":"14268_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","unstructured":"EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol"},{"issue":"1","key":"14268_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380. https:\/\/doi.org\/10.1002\/hep.29086.","journal-title":"Hepatology"},{"issue":"3","key":"14268_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137(3):850\u20135. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.003.","journal-title":"Gastroenterology"},{"issue":"2","key":"14268_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0168-8278(02)00360-4","volume":"38","author":"H Imamura","year":"2003","unstructured":"Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38(2):200\u20137. https:\/\/doi.org\/10.1016\/s0168-8278(02)00360-4.","journal-title":"J Hepatol"},{"issue":"7","key":"14268_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.ejso.2018.04.018","volume":"44","author":"D Moris","year":"2018","unstructured":"Moris D, Tsilimigras DI, Kostakis ID, Ntanasis-Stathopoulos I, Shah KN, Felekouras E, et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2018;44(7):927\u201338. https:\/\/doi.org\/10.1016\/j.ejso.2018.04.018.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"14268_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00423-011-0784-9","volume":"396","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Xu D, Wu L, Li B. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg. 2011;396(7):1109\u201317. https:\/\/doi.org\/10.1007\/s00423-011-0784-9.","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"14268_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3349\/ymj.2009.50.6.789","volume":"50","author":"H Kim","year":"2009","unstructured":"Kim H, Park MS, Park YN, Kim H, Kim KS, Choi JS, et al. Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection. Yonsei Med J. 2009;50(6):789\u201395. https:\/\/doi.org\/10.3349\/ymj.2009.50.6.789.","journal-title":"Yonsei Med J"},{"issue":"5","key":"14268_CR8","first-page":"321","volume":"23","author":"[Evidence-based","year":"2015","unstructured":"[Evidence-based. Practice guidelines for standardized pathological diagnosis of primary liver cancer in China: 2015]. Zhonghua Gan Zang Bing Za Zhi. 2015;23(5):321\u20137.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"42","key":"14268_CR9","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.3748\/wjg.v22.i42.9279","volume":"22","author":"WM Cong","year":"2016","unstructured":"Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016;22(42):9279\u201387. https:\/\/doi.org\/10.3748\/wjg.v22.i42.9279.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"14268_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/sla.0000000000003268","volume":"273","author":"S Lee","year":"2021","unstructured":"Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564\u201371. https:\/\/doi.org\/10.1097\/sla.0000000000003268.","journal-title":"Ann Surg"},{"issue":"4","key":"14268_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s11605-019-04134-y","volume":"23","author":"T Ryu","year":"2019","unstructured":"Ryu T, Takami Y, Wada Y, Tateishi M, Hara T, Yoshitomi M, et al. A clinical scoring system for predicting microvascular invasion in patients with hepatocellular carcinoma within the Milan criteria. J Gastrointest Surg. 2019;23(4):779\u201387. https:\/\/doi.org\/10.1007\/s11605-019-04134-y.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"14268_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000513704","volume":"10","author":"SB Hong","year":"2021","unstructured":"Hong SB, Choi SH, Kim SY, Shim JH, Lee SS, Byun JH, et al. MRI features for predicting microvascular invasion of hepatocellular carcinoma: A systematic review and Meta-Analysis. Liver Cancer. 2021;10(2):94\u2013106. https:\/\/doi.org\/10.1159\/000513704.","journal-title":"Liver Cancer"},{"issue":"3","key":"14268_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1148\/radiol.2020191470","volume":"294","author":"GW Ji","year":"2020","unstructured":"Ji GW, Zhu FP, Xu Q, Wang K, Wu MY, Tang WW, et al. Radiomic features at Contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: A Multi-Institutional study. Radiology. 2020;294(3):568\u201379. https:\/\/doi.org\/10.1148\/radiol.2020191470.","journal-title":"Radiology"},{"issue":"4","key":"14268_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","volume":"151","author":"Z Lei","year":"2016","unstructured":"Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for preoperative Estimation of microvascular invasion risk in hepatitis B Virus-Related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151(4):356\u201363. https:\/\/doi.org\/10.1001\/jamasurg.2015.4257.","journal-title":"JAMA Surg"},{"issue":"1","key":"14268_CR15","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1038\/s41598-021-82058-x","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Guo Y, Zhong J, Wang Q, Wang X, Wei H, et al. The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. Sci Rep. 2021;11(1):2415. https:\/\/doi.org\/10.1038\/s41598-021-82058-x.","journal-title":"Sci Rep"},{"issue":"4","key":"14268_CR16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jhep.2014.11.005","volume":"62","author":"N Pot\u00e9","year":"2015","unstructured":"Pot\u00e9 N, Cauchy F, Albuquerque M, Voitot H, Belghiti J, Castera L, et al. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion. J Hepatol. 2015;62(4):848\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.005.","journal-title":"J Hepatol"},{"issue":"6","key":"14268_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jhep.2014.01.027","volume":"60","author":"SW Suh","year":"2014","unstructured":"Suh SW, Lee KW, Lee JM, You T, Choi Y, Kim H, et al. Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection. J Hepatol. 2014;60(6):1219\u201324. https:\/\/doi.org\/10.1016\/j.jhep.2014.01.027.","journal-title":"J Hepatol"},{"key":"14268_CR18","doi-asserted-by":"publisher","unstructured":"Lee JC, Hung HC, Wang YC, Cheng CH, Wu TH, Lee CF, et al. Risk score model for microvascular invasion in hepatocellular carcinoma: the role of tumor burden and Alpha-Fetoprotein. Cancers (Basel). 2021;13(17). https:\/\/doi.org\/10.3390\/cancers13174403.","DOI":"10.3390\/cancers13174403"},{"issue":"7","key":"14268_CR19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1053\/gast.2001.24798","volume":"120","author":"P Laurent-Puig","year":"2001","unstructured":"Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 2001;120(7):1763\u201373. https:\/\/doi.org\/10.1053\/gast.2001.24798.","journal-title":"Gastroenterology"},{"issue":"11","key":"14268_CR20","doi-asserted-by":"publisher","first-page":"E1317","DOI":"10.1073\/pnas.1500076112","volume":"112","author":"P Jiang","year":"2015","unstructured":"Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, Wong VW, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A. 2015;112(11):E1317\u201325. https:\/\/doi.org\/10.1073\/pnas.1500076112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"14268_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.30811","volume":"71","author":"JC Nault","year":"2020","unstructured":"Nault JC, Martin Y, Caruso S, Hirsch TZ, Bayard Q, Calderaro J, et al. Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma. Hepatology. 2020;71(1):164\u201382. https:\/\/doi.org\/10.1002\/hep.30811.","journal-title":"Hepatology"},{"issue":"2","key":"14268_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.21037\/hbsn.2019.09.17","volume":"10","author":"S Wang","year":"2021","unstructured":"Wang S, Shi H, Liu T, Li M, Zhou S, Qiu X, et al. Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary Surg Nutr. 2021;10(2):172\u20139. https:\/\/doi.org\/10.21037\/hbsn.2019.09.17.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"2","key":"14268_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/hep.26402","volume":"58","author":"K Wang","year":"2013","unstructured":"Wang K, Lim HY, Shi S, Lee J, Deng S, Xie T, et al. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma. Hepatology. 2013;58(2):706\u201317. https:\/\/doi.org\/10.1002\/hep.26402.","journal-title":"Hepatology"},{"issue":"3","key":"14268_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.20847","volume":"42","author":"RR Plentz","year":"2005","unstructured":"Plentz RR, Schlegelberger B, Flemming P, Gebel M, Kreipe H, Manns MP, et al. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Hepatology. 2005;42(3):522\u20136. https:\/\/doi.org\/10.1002\/hep.20847.","journal-title":"Hepatology"},{"issue":"6","key":"14268_CR25","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/hep.510290636","volume":"29","author":"N Kusano","year":"1999","unstructured":"Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology. 1999;29(6):1858\u201362. https:\/\/doi.org\/10.1002\/hep.510290636.","journal-title":"Hepatology"},{"issue":"5","key":"14268_CR26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jhep.2020.11.052","volume":"74","author":"M Ningarhari","year":"2021","unstructured":"Ningarhari M, Caruso S, Hirsch TZ, Bayard Q, Franconi A, V\u00e9die AL, et al. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target. J Hepatol. 2021;74(5):1155\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.052.","journal-title":"J Hepatol"},{"issue":"2","key":"14268_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000367754","volume":"5","author":"LC Lu","year":"2016","unstructured":"Lu LC, Hsu CH, Hsu C, Cheng AL. Tumor heterogeneity in hepatocellular carcinoma: facing the challenges. Liver Cancer. 2016;5(2):128\u201338. https:\/\/doi.org\/10.1159\/000367754.","journal-title":"Liver Cancer"},{"issue":"4","key":"14268_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of Circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223\u201338. https:\/\/doi.org\/10.1038\/nrc.2017.7.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"14268_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13046-021-01940-8","volume":"40","author":"Y Li","year":"2021","unstructured":"Li Y, Zheng Y, Wu L, Li J, Ji J, Yu Q, et al. Current status of ctdna in precision oncology for hepatocellular carcinoma. J Exp Clin Cancer Res. 2021;40(1):140. https:\/\/doi.org\/10.1186\/s13046-021-01940-8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"14268_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","volume":"18","author":"Q Ye","year":"2019","unstructured":"Ye Q, Ling S, Zheng S, Xu X. Liquid biopsy in hepatocellular carcinoma: Circulating tumor cells and Circulating tumor DNA. Mol Cancer. 2019;18(1):114. https:\/\/doi.org\/10.1186\/s12943-019-1043-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"14268_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13046-018-0893-1","volume":"37","author":"J Li","year":"2018","unstructured":"Li J, Han X, Yu X, Xu Z, Yang G, Liu B, et al. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: Circulating tumor cells and Circulating tumor DNA. J Exp Clin Cancer Res. 2018;37(1):213. https:\/\/doi.org\/10.1186\/s13046-018-0893-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"14268_CR32","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/annonc\/mdy083","volume":"29","author":"CKY Ng","year":"2018","unstructured":"Ng CKY, Di Costanzo GG, Tosti N, Paradiso V, Coto-Llerena M, Roscigno G, et al. Genetic profiling using plasma-derived cell-free DNA in therapy-na\u00efve hepatocellular carcinoma patients: a pilot study. Ann Oncol. 2018;29(5):1286\u201391. https:\/\/doi.org\/10.1093\/annonc\/mdy083.","journal-title":"Ann Oncol"},{"issue":"17","key":"14268_CR33","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1158\/1078-0432.Ccr-18-3477","volume":"25","author":"Z Cai","year":"2019","unstructured":"Cai Z, Chen G, Zeng Y, Dong X, Li Z, Huang Y, et al. Comprehensive liquid profiling of Circulating tumor DNA and protein biomarkers in Long-Term Follow-Up patients with hepatocellular carcinoma. Clin Cancer Res. 2019;25(17):5284\u201394. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-3477.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"14268_CR34","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1158\/1078-0432.Ccr-20-0401","volume":"26","author":"S Zeng","year":"2020","unstructured":"Zeng S, Ying Y, Xing N, Wang B, Qian Z, Zhou Z, et al. Noninvasive detection of urothelial carcinoma by Cost-effective Low-coverage Whole-genome sequencing from Urine-Exfoliated cell DNA. Clin Cancer Res. 2020;26(21):5646\u201354. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-0401.","journal-title":"Clin Cancer Res"},{"key":"14268_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.breast.2020.07.004","volume":"53","author":"H Mo","year":"2020","unstructured":"Mo H, Wang X, Ma F, Qian Z, Sun X, Yi Z, et al. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer. Breast. 2020;53:111\u20138. https:\/\/doi.org\/10.1016\/j.breast.2020.07.004.","journal-title":"Breast"},{"issue":"3","key":"14268_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7150\/jca.10747","volume":"6","author":"H Xu","year":"2015","unstructured":"Xu H, Zhu X, Xu Z, Hu Y, Bo S, Xing T, et al. Non-invasive analysis of genomic copy number variation in patients with hepatocellular carcinoma by next generation DNA sequencing. J Cancer. 2015;6(3):247\u201353. https:\/\/doi.org\/10.7150\/jca.10747.","journal-title":"J Cancer"},{"issue":"8","key":"14268_CR37","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/liv.14463","volume":"40","author":"D Wang","year":"2020","unstructured":"Wang D, Xu Y, Goldstein JB, Ye K, Hu X, Xiao L, et al. Preoperative evaluation of microvascular invasion with Circulating tumour DNA in operable hepatocellular carcinoma. Liver Int. 2020;40(8):1997\u20132007. https:\/\/doi.org\/10.1111\/liv.14463.","journal-title":"Liver Int"},{"key":"14268_CR38","doi-asserted-by":"publisher","first-page":"783109","DOI":"10.3389\/fonc.2022.783109","volume":"12","author":"Z Xin","year":"2022","unstructured":"Xin Z, Li J, Zhang H, Zhou Y, Song J, Chen P, et al. Cancer genomic alterations can be potential biomarkers predicting microvascular invasion and early recurrence of hepatocellular carcinoma. Front Oncol. 2022;12:783109. https:\/\/doi.org\/10.3389\/fonc.2022.783109.","journal-title":"Front Oncol"},{"issue":"5","key":"14268_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21037\/atm.2019.12.154","volume":"8","author":"J Wang","year":"2020","unstructured":"Wang J, Huang A, Wang YP, Yin Y, Fu PY, Zhang X, et al. Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma. Ann Transl Med. 2020;8(5):237. https:\/\/doi.org\/10.21037\/atm.2019.12.154.","journal-title":"Ann Transl Med"},{"issue":"1","key":"14268_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0030-1247133","volume":"30","author":"A Forner","year":"2010","unstructured":"Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61\u201374. https:\/\/doi.org\/10.1055\/s-0030-1247133.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"14268_CR41","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","volume":"8","author":"VA Adalsteinsson","year":"2017","unstructured":"Adalsteinsson VA, Ha G, Freeman SS, Choudhury AD, Stover DG, Parsons HA, et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun. 2017;8(1):1324. https:\/\/doi.org\/10.1038\/s41467-017-00965-y.","journal-title":"Nat Commun"},{"issue":"16","key":"14268_CR42","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and samtools. Bioinformatics. 2009;25(16):2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinformatics"},{"key":"14268_CR43","unstructured":"Seshan VE, Olshen A. DNAcopy: DNA copy number data analysis. 2013."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14268-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:33:30Z","timestamp":1747157610000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14268-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14268"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14268-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research was conducted in accordance with both the Declarations of Helsinki and Istanbul. All research was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang (Approval No.: IIT20220097B). This study was registered at  on 16 May 2022, retrospectively registered, Registration number: NCT05371873. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"867"}}